For partners
Measurement at the scale of populations.
For health systems, payers, and research organizations: objective Parkinson’s measurement across whole populations, not one visit at a time.
This is what population-scale measurement looks like in practice. Instead of waiting for the next scheduled visit, your care team can see who is holding steady and who has started to change, and reach the people who need attention first.
The economic case
Demand is rising faster than the care can keep up.
Parkinson’s is the fastest growing neurological disorder in the world, and the specialists equipped to manage it are already stretched thin. When care is this scarce, the question is how to use it well, and that is a question measurement can help answer.
Make specialist time go further
There are only 660 movement-disorder specialists in the entire US, and patients who reach specialist care live longer and stay out of nursing facilities more often than those who do not. Continuous measurement lets that scarce expertise stretch across far more patients than in-person visits alone ever could.
Send attention where it is needed
Most patients are stable most of the time, and they do not need to be seen more often. By surfacing the few who have genuinely changed, Velsyna helps your care teams spend their hours on the people who need them now, rather than on routine check-ins that could have waited.
Build the evidence for value-based care
Outcome-based contracts depend on objective, longitudinal measures of how patients are actually doing. Velsyna produces exactly that kind of standardized, continuous data, which gives you a real foundation to negotiate and report against.
What you receive
Data your analysts can actually use.
Standardized measures
Every score is expressed on MDS-UPDRS-aligned 0 to 4 conventions, so results connect to the frameworks your teams already report against.
Longitudinal, consented records
Measurement collected week after week with patient consent, and medication context recorded on the same timeline as the scores.
Structured, analysis-ready exports
Organized data your analysts can work with directly, for registries, internal review, and clinical trial support.
Research and life sciences
Structured data for research.
Trials and registries increasingly ask for standardized, real-world measures collected over time. That is precisely the kind of data Velsyna is designed to produce, and we can shape it around the endpoints your study needs.
Digital endpoints that align with the MDS-UPDRS, so results connect to the measures trials already recognize.
Consistent capture protocols at home and in clinic, for cleaner comparisons across sites and studies.
Start a conversation.
If you are responsible for a population that includes people with Parkinson’s, we would welcome the chance to talk through how objective measurement could fit into your work.